SIRT4 functions as a tumor suppressor during prostate cancer by inducing apoptosis and inhibiting glutamine metabolism
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SIRT4 functions as a tumor suppressor during prostate cancer by inducing apoptosis and inhibiting glutamine metabolism
Authors
Keywords
-
Journal
Scientific Reports
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-07-16
DOI
10.1038/s41598-022-16610-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy
- (2019) Ali F. Abdel-Wahab et al. PHARMACOLOGICAL RESEARCH
- SIRT4 regulates cancer cell survival and growth after stress
- (2016) Seung Min Jeong et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Emerging Hallmarks of Cancer Metabolism
- (2016) Natalya N. Pavlova et al. Cell Metabolism
- The caspase-activated DNase: apoptosis and beyond
- (2016) Brian D. Larsen et al. FEBS Journal
- Clinical and therapeutic significance of sirtuin-4 expression in colorectal cancer
- (2016) GUOYU HUANG et al. ONCOLOGY REPORTS
- Sirtuin-4 (SIRT4) is downregulated and associated with some clinicopathological features in gastric adenocarcinoma
- (2015) Guoyu Huang et al. BIOMEDICINE & PHARMACOTHERAPY
- Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a correlative study to explore potential biomarkers for response
- (2015) Winnie Yeo et al. BMC CANCER
- Tumour-suppressive function of SIRT4 in human colorectal cancer
- (2015) M Miyo et al. BRITISH JOURNAL OF CANCER
- Apoptotic effects of high-dose rapamycin occur in S-phase of the cell cycle
- (2015) Mahesh Saqcena et al. CELL CYCLE
- Intermittent Chemotherapy as a Platform for Testing Novel Agents in Patients With Metastatic Castration-Resistant Prostate Cancer: A Department of Defense Prostate Cancer Clinical Trials Consortium Randomized Phase II Trial of Intermittent Docetaxel With Prednisone With or Without Maintenance GM-CSF
- (2015) Rahul R. Aggarwal et al. Clinical Genitourinary Cancer
- Sirtuin 4 Is a Lipoamidase Regulating Pyruvate Dehydrogenase Complex Activity
- (2014) Rommel A. Mathias et al. CELL
- Blocking anaplerotic entry of glutamine into the TCA cycle sensitizes K-Ras mutant cancer cells to cytotoxic drugs
- (2014) M Saqcena et al. ONCOGENE
- Caspase crosstalk: integration of apoptotic and innate immune signalling pathways
- (2014) Emma M. Creagh TRENDS IN IMMUNOLOGY
- SIRT4 Has Tumor-Suppressive Activity and Regulates the Cellular Metabolic Response to DNA Damage by Inhibiting Mitochondrial Glutamine Metabolism
- (2013) Seung Min Jeong et al. CANCER CELL
- The mTORC1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation by Repressing SIRT4
- (2013) Alfred Csibi et al. CELL
- Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells
- (2012) Anne Le et al. Cell Metabolism
- Metabolic reprogramming in cancer: Unraveling the role of glutamine in tumorigenesis
- (2012) Dania Daye et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- SIRT4 Regulates Fatty Acid Oxidation and Mitochondrial Gene Expression in Liver and Muscle Cells
- (2010) Nargis Nasrin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Recent progress in the biology and physiology of sirtuins
- (2009) Toren Finkel et al. NATURE
- Glutamine Deprivation Induces Abortive S-Phase Rescued by Deoxyribonucleotides in K-Ras Transformed Fibroblasts
- (2009) Daniela Gaglio et al. PLoS One
- The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
- (2008) Ralph J. DeBerardinis et al. Cell Metabolism
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started